Can a Wilson Disease Carrier Donate Part of Their Liver to Me?

When you are facing a liver transplant for Wilson disease, the idea of a family member donating a portion of their liver is both comforting and complicated. The encouraging news is that having a parent or sibling who is a Wilson disease carrier does not automatically disqualify them as a living donor. Transplant centres have successfully used carrier donors, and outcomes are generally good.¹ But the process involves a careful medical evaluation that looks beyond genetics, and the final answer belongs to the transplant team — not to a general rule.

What does “carrier” actually mean here?

Wilson disease is autosomal recessive: a person develops the disease only if they inherit a faulty copy of the ATP7B gene from both parents. A carrier — sometimes called a heterozygote — has one working copy and one faulty copy. Carriers do not develop Wilson disease themselves and typically have normal liver function, though they may have very mildly elevated liver copper levels that never cause symptoms.²

Your parents are almost certainly carriers (each gave you one of your two faulty copies). Your siblings have a 25% chance of having Wilson disease themselves, a 50% chance of being carriers, and a 25% chance of being entirely unaffected. If you are asking about donating, the first step is genetic and medical screening to confirm their status.

The key question: is the carrier’s liver healthy enough to donate?

The most important thing the transplant team wants to know is not just whether a person is a carrier — it is whether their liver is healthy. Living donor liver transplant (LDLT) requires removing a significant portion (usually 60–70%) of a healthy person’s liver.³ That is a major surgery with real risks for the donor, including bleeding, bile leaks, and the rare but serious risk of liver failure in the remaining segment. A transplant centre will only proceed if the donor’s remaining liver segment is sufficient to sustain them safely.

For a Wilson disease carrier, this evaluation typically includes:

• Liver function tests — to confirm normal or near-normal function
• Liver biopsy — some centres request this to directly assess copper content and rule out subclinical fibrosis
• Ceruloplasmin and serum copper — usually normal in carriers, but formally checked
• Imaging — to assess liver volume and anatomy before deciding which portion can be safely removed
• Genetic confirmation — to formally document carrier status and rule out the possibility that the family member actually has Wilson disease themselves (occasionally a person can have the disease with very mild presentation)

Published series of LDLT for Wilson disease have included carrier donors and found that their donated liver segments perform well in the recipient, because the functional ATP7B gene copy in the donor’s liver cells is sufficient to handle copper normally after transplant.¹⁴

Will the transplanted portion develop Wilson disease in me?

This is an important and sometimes overlooked question. When you receive a liver from a carrier, the transplanted cells contain one working copy of the ATP7B gene. That single working copy is enough. The transplanted liver will manage copper normally — you will not develop Wilson disease in the new liver, and you will not need to continue copper-chelating medications after a successful transplant.⁴

This is a genuine biological cure for the liver disease component of Wilson disease. If you had significant neurological involvement before transplant, that is a separate conversation — transplant does not always reverse established neurological damage, though it may stop further progression.¹

What makes a carrier donor more complicated than a standard donor?

The ethical and practical complexity of using a family member as a living donor exists regardless of carrier status — donors undergo major surgery without personal medical benefit, and the decision must be fully voluntary. Transplant programmes have formal independent evaluation processes specifically to make sure potential donors are not feeling pressured by family expectations.⁵

Carrier status adds one layer: the transplant team wants to confirm that the donor’s own liver health is not subtly compromised. Most carriers do fine on evaluation. But occasionally a carrier is found to have mildly elevated liver enzymes, borderline copper accumulation, or early fibrosis — none of these would cause health problems in daily life, but they might affect candidacy as a living donor. In those cases, the team may decline or seek an alternative donor.

Are there situations where a carrier cannot donate?

Yes, though they are not the majority. A carrier donor may be ruled out if:

• Their remaining liver volume after donation would be inadequate for their own safety
• Biopsy shows significant copper accumulation or early fibrosis (unusual but possible)
• They have another unrelated liver condition (fatty liver, alcohol-related changes, etc.)
• Their anatomy is not suitable for the kind of resection the recipient needs
• They are not medically fit for major abdominal surgery in general

None of this means the answer will be no. It means the answer requires an actual evaluation.

What if no carrier donor is available or eligible?

Deceased donor transplant remains the primary pathway for most Wilson disease patients who need transplant. Living donation from a completely unrelated healthy person is also possible. The waiting time and prognosis depend heavily on how urgently you need a transplant and the regional organ allocation rules where you are being treated. Your transplant hepatologist is the right person to map out the options given your specific situation.

See also: overview of Wilson disease medications for context on how medical therapy is tried before transplant is considered, and what to tell your doctor for guidance on preparing for specialist appointments.

The short version

• A carrier parent or sibling can, in many cases, safely donate a portion of their liver.¹
• The transplant team will fully evaluate the donor’s liver health independently of their carrier status.³
• The transplanted liver portion — carrying one working ATP7B copy — will handle copper normally after surgery.⁴
• Family members should feel free to offer but should never feel obligated; the evaluation process is designed to protect them.⁵
• Final candidacy is determined by the transplant centre’s multi-disciplinary evaluation, not by a general rule.

This article is patient education, not medical advice. Living donor evaluation involves many medical and ethical factors that are specific to each potential donor and recipient pair. Decisions about liver transplant should be made in partnership with a specialist transplant programme.

References